Why the study?
Does intensive glycemic control prevent cardiovascular events in patients with type 2 diabetes?
Does intensive glycemic control prevent cardiovascular events in patients with type 2 diabetes?
This joint scientific statement recommends an A1C target of <7.0% for most patients with type 2 diabetes to prevent cardiovascular events.
No abstract was published with this document — society guidelines, consensus pathways, and scientific statements are typically released without one. See the Key Points and the linked PDF for the full content.
No takes yet. Share an insight, caveat, or question.
Lund et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: